Round Table of Companies

Established in 2019, RDNZ's Round Table of Companies is a group of pharmaceutical companies with a common interest in rare disorders and orphan drug development.

The Round Table of Companies provides an important forum to foster transparent working relationships with industry and encourage open communication between industry and the rare disorder patient community. Maintaining independence and integrity is of the utmost priority to RDNZ.

The Round Table of Companies holds two meetings annually to discuss topics relevant to the development of orphan drugs and treatments for rare disorders in New Zealand.

We welcome other pharmaceutical companies with an interest in rare disorders and orphan drug development to join the Round Table of Companies.

Please read our below policy documents and contact enquiries@raredisorders.org.nz if your company would like to apply for membership.

Policy Documents

Membership to RTC

Position Statement on Financial Support from Pharmaceutical Industry

RDNZ policy on working with the Pharmaceutical Industry

Round Table of Companies MoU

Current members